检索

期
标题
作者
卷 11, 编号 1 (2014)
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components
Zhernakova Y., Sharipova G., Chazova I.
PDF
(Rus)
卷 16, 编号 4 (2019)
Vascular wall status and its link with perivascular adipose tissue and other fat depots in young patients with abdominal obesity
Zheleznova E., Zhernakova J., Pogorelova O., Tripoten M., Blinova N., Shariya M., Azimova M., Gorieva S., Maslov A., Balakhonova T., Chazova I.
PDF
(Rus)
卷 14, 编号 1 (2017)
Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients
Zhernakova Y., Martyniuk T., Arkhipova O., Azimova M., Rogoza A., Chazova I.
PDF
(Rus)
卷 12, 编号 2 (2015)
Influence of metabolic syndrome components on the level of nitric oxide stable metabolites in patients with essential hypertension
Podzolkov V., Bragina A., Bragina G., Murashko N.
PDF
(Rus)
卷 10, 编号 2 (2013)
Use of diuretics in hypertensive patients with metabolic disturbances
Zhernakova Y., Chazova I.
卷 16, 编号 3 (2019)
The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus
Zhernakova J., Chazova I., Blinova N.
PDF
(Rus)
卷 13, 编号 4 (2016)
The patients of high cardiovascular risk of healthy: unrecognized metabolic syndrome
Blinova N., Zhernakova Y., Chazova I., Oshchepkova E.
PDF
(Rus)
卷 10, 编号 2 (2013)
Effect of angiotensin II receptor antagonists on left ventricular hypertrophy, vascular elasticity, and lipid and carbohydrate metabolic parameters in metabolic syndrome
Nedogoda S., Salasyuk A., Chalyabi T., Barykina I., Pocheptsov D., Ledyaeva A., Tsoma V., Chumachek E.
卷 6, 编号 1 (2009)
Hyperfiltration and metabolic syndrome
Arutyunov G., Oganezova L., Arutyunov G., Oganezova L.
卷 13, 编号 2 (2016)
Nephroprotective in patients with metabolic syndrome: approaches to the appointment of antihypertensive drugs
Ostroumova O., Zykova A., Maksimov M.
PDF
(Rus)
卷 11, 编号 4 (2014)
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders
Zhernakov Y., Chazova I.
PDF
(Rus)
卷 6, 编号 1 (2009)
Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome
Mychka V., Chazova I., Mychka V., Chazova I.
卷 11, 编号 2 (2014)
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders
Zhernakova Y., Chazova I.
PDF
(Rus)
卷 17, 编号 4 (2020)
Assessment of epicardial adipose tissue by echocardiography for risk stratification in young adults with abdominal obesity
Blinova N., Azimova M., Zhernakova J., Saidova M., Ternovoy S., Zheleznova E., Azimova M., Chazova I.
PDF
(Rus)
卷 6, 编号 1 (2009)
Metabolic syndrome
Mychka V., Chazova I., Mychka V., Chazova I.
卷 17, 编号 4 (2020)
Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus
Zhernakova J., Chazova I.
PDF
(Rus)
卷 15, 编号 4 (2018)
Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity
Zheleznova E., Zhernakova Y., Chazova I., Rogoza A., Zairova A., Shariya M., Yarovaya E., Orlovsky A., Blinova N., Azimova M., Gorieva S., Konosova I.
PDF
(Rus)
卷 13, 编号 1 (2016)
The possibility of perindopril in angioprotective in patients with metabolic syndrome after combination therapy with a thiazide diuretic
Nedogoda S., Smirnova V., Khripaeva V., Palashkin R., Ledyaeva A., Chumachok E., Salasyuk A.
PDF
(Rus)
卷 11, 编号 1 (2014)
Hypertension treatment features in perimenopausal women
Zhernakova Y., Chazova I.
PDF
(Rus)
卷 17, 编号 4 (2020)
Impact of metabolic syndrome parameters and different fat depots on arterial stiffness in patients with abdominal obesity
Andreevskaia M., Zheleznova E., Zhernakova J., Chazova I., Shariia M., Blinova N., Zairova A., Azimova M., Rogoza A., Saidova M.
PDF
(Rus)
卷 14, 编号 3 (2017)
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
Chazova I., Zhernakova Y., Blinova N., Rogoza A.
PDF
(Rus)
卷 12, 编号 1 (2015)
Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach
Zhernakova Y., Sharipova G., Chazova I.
PDF
(Rus)
卷 10, 编号 2 (2013)
Efficacy of irbesartan in arterial hypertension and metabolic syndrome
Ostroumova O., Zykova A., Polosova T., Bondarets O.
卷 12, 编号 1 (2015)
Effects of amlodipine and atorvastatin on endothelial vasoactive mediators in patients with metabolic syndrome
Blinova N., Masenko V., Chazova I.
PDF
(Rus)
卷 10, 编号 2 (2013)
Additional possibilities of antihypertensive therapy for metabolic syndrome
Kislyak O., Pokhilchenko M.
1 - 25 的 25 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##